Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell, Peripheral trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Phase: Phase 2 Country / region: United States Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20031
20042
20053
20064
20071
20082
20091
20103
20114
20123
20131
20142
20152
20162
20182
20195
20202
20212
20233
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated7
Recruiting5
Active, not recruiting2
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center7
National Cancer Institute (NCI)4
M.D. Anderson Cancer Center3
Acrotech Biopharma Inc.2
Affimed GmbH2
Seagen Inc.2
University of Nebraska2
Yale University2
Alaunos Therapeutics1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral54
Lymphoma, T-Cell, Cutaneous24
Lymphoma, Large-Cell, Anaplastic21
Immunoblastic Lymphadenopathy19
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma19
Hodgkin Disease18
Leukemia, Lymphocytic, Chronic, B-Cell18
Lymphoma, Non-Hodgkin18
Mycosis Fungoides18
Sezary Syndrome18

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.